SMAD3 and myeloproliferative disorder: However, the expression of pSMAD3 was significantly increased in all MPN entities, most prominently in PMF (Fig. 2c, d), indicating that patients with MPNs showed increased TGFβ/SMAD3 signaling compared to HDs.